Legal Representation
Attorney
Mark I Feldman
USPTO Deadlines
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 28, 2005 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 28, 2005 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 4, 2005 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Mar 9, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 9, 2005 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 13, 2004 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 30, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 30, 2004 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 28, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Mar 15, 2004 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 27, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 27, 2004 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 26, 2003 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 15, 2003 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 15, 2003 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 15, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 28, 2003 | I | PAPER RECEIVED | Loading... | |
| Mar 24, 2003 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 24, 2002 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 25, 2002 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Feb 12, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 23, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Nov 14, 2001 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 22, 2001 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| May 14, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| May 9, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in the treatment of oncological, neurological, endocrinological, inflammatory and urological diseases and disorders and renal diseases, and complications associated therewith
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005